JP2008291001A - 皮膚化粧料及び美容用飲食品 - Google Patents
皮膚化粧料及び美容用飲食品 Download PDFInfo
- Publication number
- JP2008291001A JP2008291001A JP2007141137A JP2007141137A JP2008291001A JP 2008291001 A JP2008291001 A JP 2008291001A JP 2007141137 A JP2007141137 A JP 2007141137A JP 2007141137 A JP2007141137 A JP 2007141137A JP 2008291001 A JP2008291001 A JP 2008291001A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- action
- production
- nail
- falcon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 235000013305 food Nutrition 0.000 title claims abstract description 24
- 230000003796 beauty Effects 0.000 title claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 132
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 50
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 31
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 29
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 27
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 26
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 25
- 239000003112 inhibitor Substances 0.000 claims abstract description 25
- 239000004480 active ingredient Substances 0.000 claims abstract description 23
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 121
- 238000004519 manufacturing process Methods 0.000 claims description 104
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 81
- 230000002401 inhibitory effect Effects 0.000 claims description 73
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 61
- 230000009471 action Effects 0.000 claims description 57
- 230000001737 promoting effect Effects 0.000 claims description 52
- 230000008099 melanin synthesis Effects 0.000 claims description 42
- 230000002000 scavenging effect Effects 0.000 claims description 39
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 claims description 31
- 108010024636 Glutathione Proteins 0.000 claims description 30
- 229960003180 glutathione Drugs 0.000 claims description 30
- 108010028309 kalinin Proteins 0.000 claims description 28
- 102000004266 Collagen Type IV Human genes 0.000 claims description 27
- 108010042086 Collagen Type IV Proteins 0.000 claims description 27
- 230000002087 whitening effect Effects 0.000 claims description 27
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims description 25
- 230000002292 Radical scavenging effect Effects 0.000 claims description 24
- 230000037319 collagen production Effects 0.000 claims description 21
- 230000006433 tumor necrosis factor production Effects 0.000 claims description 20
- 230000005779 cell damage Effects 0.000 claims description 18
- 208000037887 cell injury Diseases 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 13
- 244000171168 Desmos chinensis Species 0.000 abstract description 3
- 241000926826 Desmos cochinchinensis Species 0.000 abstract description 3
- 239000007854 depigmenting agent Substances 0.000 abstract 2
- 230000003061 melanogenesis Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 51
- 239000000523 sample Substances 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 36
- 238000012360 testing method Methods 0.000 description 35
- 239000000243 solution Substances 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 238000002835 absorbance Methods 0.000 description 31
- 239000012488 sample solution Substances 0.000 description 30
- 238000000605 extraction Methods 0.000 description 24
- 235000006708 antioxidants Nutrition 0.000 description 23
- 239000000203 mixture Substances 0.000 description 21
- 238000011282 treatment Methods 0.000 description 17
- 230000005764 inhibitory process Effects 0.000 description 16
- 230000002265 prevention Effects 0.000 description 15
- 239000002609 medium Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000001301 oxygen Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- -1 lipid peroxides Chemical class 0.000 description 10
- 230000009759 skin aging Effects 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 7
- 240000008620 Fagopyrum esculentum Species 0.000 description 7
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 7
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 7
- 102000003390 tumor necrosis factor Human genes 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000008030 elimination Effects 0.000 description 6
- 238000003379 elimination reaction Methods 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 229930014626 natural product Natural products 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 210000002469 basement membrane Anatomy 0.000 description 5
- 210000000078 claw Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 208000027866 inflammatory disease Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 230000037373 wrinkle formation Effects 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000009137 Behcet syndrome Diseases 0.000 description 3
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000026062 Tissue disease Diseases 0.000 description 2
- 206010054094 Tumour necrosis Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000011481 absorbance measurement Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000066 endothelium dependent relaxing factor Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-L 5-[(3-carboxylato-4-nitrophenyl)disulfanyl]-2-nitrobenzoate Chemical compound C1=C([N+]([O-])=O)C(C(=O)[O-])=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C([O-])=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-L 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000234270 Amaryllidaceae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 241000447394 Desmos Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 201000011152 Pemphigus Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000019209 bilberry extract Nutrition 0.000 description 1
- 229940102480 bilberry extract Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000004654 carnosol Nutrition 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000010001 cellular homeostasis Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000033770 negative regulation of tumor necrosis factor production Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 201000001976 pemphigus vulgaris Diseases 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033904 relaxation of vascular smooth muscle Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 230000008427 tissue turnover Effects 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Abstract
【解決手段】抗酸化剤、抗老化剤、抗炎症剤、美白剤、メラニン産生抑制剤、皮膚化粧料又は美容用飲食品に、仮鷹爪(Desmos chinensis Lour.;Desmos cochinchinensis Lour.)からの抽出物を有効成分として含有せしめる。
【選択図】なし
Description
〔抗酸化剤,抗老化剤,抗炎症剤,美白剤,メラニン産生抑制剤〕
本発明の抗酸化剤、抗老化剤、抗炎症剤、美白剤又はメラニン産生抑制剤は、仮鷹爪からの抽出物を有効成分として含有する。
仮鷹爪からの抽出物は、スーパーオキサイド消去作用、ラジカル消去作用、過酸化水素消去作用、グルタチオン産生促進作用、IV型コラーゲン産生促進作用、ラミニン5産生促進作用、過酸化水素による細胞傷害の予防・改善作用、一酸化窒素産生抑制作用、腫瘍壊死因子産生抑制作用、血小板凝集抑制作用又はメラニン産生抑制作用を有しており、皮膚に適用した場合の使用感と安全性とに優れているため、皮膚化粧料に配合するのに好適である。この場合、皮膚化粧料には、仮鷹爪からの抽出物を配合してもよいし、仮鷹爪からの抽出物から製剤化した抗酸化剤、抗老化剤、抗炎症剤、美白剤又はメラニン産生抑制剤を配合してもよい。仮鷹爪からの抽出物、上記抗酸化剤、上記抗老化剤、上記抗炎症剤、上記美白剤又は上記メラニン産生抑制剤を皮膚化粧料に配合することによって、皮膚化粧料にスーパーオキサイド消去作用、ラジカル消去作用、過酸化水素消去作用、グルタチオン産生促進作用、IV型コラーゲン産生促進作用、ラミニン5産生促進作用、過酸化水素による細胞傷害の予防・改善作用、一酸化窒素産生抑制作用、腫瘍壊死因子産生抑制作用、血小板凝集抑制作用又はメラニン産生抑制作用を付与することができる。
上記仮鷹爪からの抽出物は、スーパーオキサイド消去作用、ラジカル消去作用、過酸化水素消去作用、グルタチオン産生促進作用、IV型コラーゲン産生促進作用、ラミニン5産生促進作用、過酸化水素による細胞傷害の予防・改善作用、一酸化窒素産生抑制作用、腫瘍壊死因子産生抑制作用、血小板凝集抑制作用又はメラニン産生抑制作用を有しており、消化管で消化されるようなものではないことが確認されており、安全性にも優れているため、美容用飲食品に配合するのに好適である。この場合に、仮鷹爪からの抽出物をそのまま配合してもよいし、仮鷹爪からの抽出物から製剤化した抗酸化剤、抗老化剤、抗炎症剤、美白剤又はメラニン産生抑制剤を配合してもよい。
仮鷹爪の葉部の粗粉砕物100gに抽出溶媒1000mLを加え、穏やかに攪拌しながら80℃にて2時間保ち、熱時濾過した。得られた抽出液を40℃で減圧下にて濃縮し、減圧乾燥機で乾燥して仮鷹爪葉部抽出物を得た。抽出溶媒として、水、50質量%エタノール(水とエタノールとの質量比1:1)、80質量%エタノール(水とエタノールとの質量比1:4)を用いたときの各抽出物の収率を表1に示す。
試 料 抽出溶媒 抽出物収率(%)
1 水 20.2
2 50%エタノール 22.0
3 80%エタノール 18.4
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにしてスーパーオキサイド消去作用を試験した。
上記式において、Aは「酵素溶液添加・試料溶液添加時の吸光度」を、Bは「酵素溶液無添加・試料溶液添加時の吸光度」を、Cは「酵素溶液添加・試料溶液無添加時の吸光度」を、Dは「酵素溶液無添加・試料溶液無添加時の吸光度」を示す。
上記試験の結果を表2に示す。
試 料 IC 50 (μg/mL)
1 96.3
2 88.4
3 92.7
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにしてラジカル消去作用を試験した。
ただし、上記式において、Aは「コントロールの吸光度」を、Bは「試料溶液添加時の吸光度」を、Cは「ブランクの吸光度」を表す。
上記試験の結果を表3に示す。
試 料 IC 50 (μg/mL)
1 201.4
2 185.3
3 194.8
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにして過酸化水素消去作用を試験した。
ただし、上記式において、Aは「過酸化水素標準溶液添加・試料溶液添加時の吸光度」を、Bは「過酸化水素標準溶液無添加・試料溶液添加時の吸光度」を、Cは「過酸化水素標準溶液添加・試料溶液無添加時の吸光度」を表し、Dは「過酸化水素標準溶液無添加・試料溶液無添加時の吸光度」を表す。
上記試験の結果を表4に示す。
試 料 IC 50 (μg/mL)
1 18.6
2 14.7
3 17.9
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにしてグルタチオン産生促進作用を試験した。
上記式において、Aは「試料無添加時の細胞中における総タンパク量あたりのグルタチオン量」を、Bは「試料添加時の細胞中における総タンパク量あたりのグルタチオン量」を表す。
上記試験の結果を表5に示す。
試 料 グルタチオン産生促進率(%)
1 309.2
2 425.8
3 351.3
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにしてIV型コラーゲン産生促進作用を試験した。
上記式において、Aは「試料添加時のIV型コラーゲン量」を、Bは「試料無添加時のIV型コラーゲン量」を表す。
上記試験結果を表6に示す。
試 料 IV型コラーゲン産生促進率(%)
1 131.2
2 140.5
3 128.6
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにしてラミニン5産生促進作用を試験した。
上記式において、Aは「試料添加時のラミニン5産生量」を、Bは「試料無添加時のラミニン5産生量」を表す。
上記試験結果を表7に示す。
試 料 ラミニン5産生促進率(%)
1 108.7
2 118.8
3 112.3
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにして過酸化水素による細胞障害の予防・改善作用を試験した。
上記式において、Ntは「試料溶液無添加・過酸化水素溶液無添加時の吸光度」を、Cは「試料溶液無添加・過酸化水素溶液添加時の吸光度」を、Saは「試料溶液天下・過酸化水素溶液添加時の吸光度」を表す。
上記試験結果を表8に示す。
試 料 細胞障害抑制率(%)
1 1.8
2 2.9
3 2.0
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにして一酸化窒素産生抑制作用を試験した。
上記式において、Aは「試料無添加時の吸光度」を、Bは「試料無添加時のブランクの吸光度」を、Cは「試料添加時の吸光度」を、Dは「試料添加時のブランクの吸光度」を表す。
上記試験結果を表9に示す。
試 料 IC 50 (μg/mL)
1 144.7
2 152.6
3 149.4
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにして腫瘍壊死因子産生抑制作用を試験した。
上記式において、Aは「試料添加時の腫瘍壊死因子量」を、Bは「試料無添加時の腫瘍壊死因子量」を表す。
上記試験結果を表10に示す。
試 料 腫瘍壊死因子産生抑制率(%)
1 15.3
2 27.9
3 20.1
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにして血小板凝集抑制作用を試験した。
採血したウサギの血液に77mmol/LのEDTA(pH7.4)を1/10量加えて、遠心(180×g,10分,室温)して血小板浮遊液(P.R.P.)を得た。さらに遠心(810×g,10分,4℃)し、上清を除去して血小板を得た。これを血小板洗浄液(0.15mol/Lの塩化ナトリウムと、0.15mol/Lのトリス塩酸緩衝液(pH7.4)と、77mmol/LのEDTA溶液(pH7.4)とを90:8:2で混合)に浮遊させ、上記と同様に遠心し、得られた血小板を血小板浮遊液(145mmol/Lの塩化ナトリウム、5mmol/Lの塩化カリウム及び5.5mmol/Lのグルコースを含む10mmol/LのHEPES緩衝液,pH7.4)に浮遊させて血小板数を調整(3.0×105cells/μL)し、洗浄血小板浮遊液を得た。
得られた洗浄血小板浮遊液222μLに200mmol/Lの塩化カルシウム溶液1μLを加え、37℃で1分間反応させた。これに試料溶液(試料濃度:400μg/mL)2μLを加え、さらに2分間反応させ、撹拌子を入れて1分間撹拌した後、コラーゲン溶液を25μL添加して、37℃の温度条件下で10分間の血小板凝集率を測定した。また、コントロールとして試料溶液を添加しない以外は同様にして血小板凝集率を測定した。得られた測定結果から、下記式により、血小板凝集抑制率(%)を算出した。
上記式において、Aは「コントロールの血小板凝集率」を表し、Bは「試料添加時の血小板凝集率」を表す。
上記試験結果を表11に示す。
試 料 血小板凝集抑制率(%)
1 12.1
2 16.7
3 13.8
製造例1により得られた仮鷹爪葉部抽出物(試料1〜3)について、以下のようにしてメラニン産生抑制作用を試験した。
上記式において、Aは「試料無添加時の475nmにおける吸光度」を、Bは「試料添加時の475nmにおける吸光度」を、Cは「試料添加時の細胞数」を、Dは「試料無添加時の細胞数」を表す。
上記試験結果を表12に示す。
試 料 メラニン産生抑制率(%)
1 33.1
2 42.6
3 39.6
下記組成の乳液を常法により製造した。
仮鷹爪水抽出物(製造例1) 0.10g
ホホバオイル 4.0g
1,3−ブチレングリコール 3.0g
ポリオキシエチレンセチルエーテル(20E.O.) 2.5g
オリーブオイル 2.0g
スクワラン 2.0g
セタノール 2.0g
モノステアリン酸グリセリル 2.0g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 2.0g
パラオキシ安息香酸メチル 0.15g
黄杞エキス 0.10g
グリチルリチン酸ジカリウム 0.10g
イチョウ葉エキス 0.10g
コンキオリン 0.10g
オウバクエキス 0.10g
カツミレエキス 0.10g
香料 0.05g
精製水 残部(全量を100gとする)
下記組成の化粧水を常法により製造した。
仮鷹爪50%エタノール抽出物(製造例1) 0.10g
グリセリン 3.0g
1,3−ブチレングリコール 3.0g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 2.0g
パラオキシ安息香酸メチル 0.15g
クエン酸 0.10g
クエン酸ソーダ 0.10g
油溶性甘草エキス 0.10g
海藻エキス 0.10g
クジンエキス 0.10g
キシロビオースミクスチャー 0.05g
香料 0.05g
精製水 残部(全量を100gとする)
下記組成のクリームを常法により製造した。
仮鷹爪80%エタノール抽出物(製造例1) 0.10g
スクワラン 10.0g
1,3−ブチレングリコール 6.0g
流動パラフィン 5.0g
サラシミツロウ 4.0g
セタノール 3.0g
モノステアリン酸グリセリル 3.0g
ラノリン 2.0g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 1.5g
パラオキシ安息香酸メチル 1.5g
ステアリン酸 1.0g
酵母抽出液 0.10g
シソ抽出液 0.10g
シナノキ抽出液 0.10g
ジユ抽出液 0.10g
香料 0.10g
精製水 残部(全量を100gとする)
下記組成のパックを常法により製造した。
仮鷹爪50%エタノール抽出物(製造例1) 0.20g
ポリビニルアルコール 15.0g
エタノール 10.0g
プロピレングリコール 7.0g
ポリエチレングリコール 3.0g
セージ抽出液 0.10g
トウキ抽出液 0.10g
ニンジン抽出液 0.10g
パラオキシ安息香酸メチル 0.05g
香料 0.05g
精製水 残部(全量を100gとする)
下記組成の錠剤状栄養補助食品を常法により製造した。
仮鷹爪水抽出物(製造例1) 30g
粉糖(ショ糖) 178g
ソルビット 10g
グリセリン脂肪酸エステル 12g
下記組成の顆粒状栄養補助食品を常法により製造した。
仮鷹爪50%エタノール抽出物(製造例1) 30g
ビートオリゴ糖 178g
ビタミンC 10g
ステビア抽出物 12g
Claims (10)
- 仮鷹爪からの抽出物を有効成分として含有することを特徴とする抗酸化剤。
- 前記抽出物が、スーパーオキサイド消去作用、ラジカル消去作用、過酸化水素消去作用及びグルタチオン産生促進作用からなる群より選ばれる1種又は2種以上の作用を有することを特徴とする請求項1に記載の抗酸化剤。
- 仮鷹爪からの抽出物を有効成分として含有することを特徴とする抗老化剤。
- 前記抽出物が、IV型コラーゲン産生促進作用、ラミニン5産生促進作用及び過酸化水素による細胞傷害の予防・改善作用からなる群より選ばれる1種又は2種以上の作用を有することを特徴とする請求項3に記載の抗老化剤。
- 仮鷹爪からの抽出物を有効成分として含有することを特徴とする抗炎症剤。
- 前記抽出物が、一酸化窒素産生抑制作用、腫瘍壊死因子産生抑制作用及び血小板凝集抑制作用からなる群より選ばれる1種又は2種以上の作用を有することを特徴とする請求項5に記載の抗炎症剤。
- 仮鷹爪からの抽出物を有効成分として含有することを特徴とする美白剤。
- 仮鷹爪からの抽出物を有効成分として含有することを特徴とするメラニン産生抑制剤。
- 仮鷹爪からの抽出物を配合したことを特徴とする皮膚化粧料。
- 仮鷹爪からの抽出物を配合したことを特徴とする美容用飲食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007141137A JP5220346B2 (ja) | 2007-05-28 | 2007-05-28 | 皮膚化粧料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007141137A JP5220346B2 (ja) | 2007-05-28 | 2007-05-28 | 皮膚化粧料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008291001A true JP2008291001A (ja) | 2008-12-04 |
JP5220346B2 JP5220346B2 (ja) | 2013-06-26 |
Family
ID=40166112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007141137A Active JP5220346B2 (ja) | 2007-05-28 | 2007-05-28 | 皮膚化粧料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5220346B2 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110305779A1 (en) * | 2010-06-10 | 2011-12-15 | Cowan Fred M | Phytochemical combinations that regulate pathological immunity |
KR101114141B1 (ko) | 2009-08-31 | 2012-02-20 | (주)아모레퍼시픽 | 항산화용 화장료 조성물 |
JP2012131748A (ja) * | 2010-12-22 | 2012-07-12 | Kao Corp | 抗酸化剤 |
CN105663595A (zh) * | 2016-02-29 | 2016-06-15 | 中国医学科学院药用植物研究所云南分所 | 一种黑色素抑制剂、护肤组合物及其应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0665075A (ja) * | 1992-06-25 | 1994-03-08 | Tonen Corp | 抗腫瘍剤 |
JPH06312919A (ja) * | 1993-05-06 | 1994-11-08 | Kao Corp | 美白剤及びこれを含有する皮膚化粧料 |
JPH06321751A (ja) * | 1993-05-07 | 1994-11-22 | Kao Corp | 美白剤 |
JPH06321754A (ja) * | 1993-05-10 | 1994-11-22 | Kao Corp | 美白剤 |
JPH06321749A (ja) * | 1993-05-07 | 1994-11-22 | Kao Corp | 美白剤 |
JPH0761919A (ja) * | 1993-08-26 | 1995-03-07 | Kao Corp | 美白剤 |
JP2003500452A (ja) * | 1999-05-27 | 2003-01-07 | アーマディーロ・ファーマシューティカルス・インコーポレーテッド | 天然資源から抽出した生物活性物質の医薬製剤 |
JP2006522150A (ja) * | 2003-04-04 | 2006-09-28 | ユニゲン・ファーマシューティカルス・インコーポレーテッド | 哺乳動物の皮膚のケアのためのシクロオキシゲナーゼ(cox)およびリポキシゲナーゼ(lox)の二重の阻害薬の製剤 |
-
2007
- 2007-05-28 JP JP2007141137A patent/JP5220346B2/ja active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0665075A (ja) * | 1992-06-25 | 1994-03-08 | Tonen Corp | 抗腫瘍剤 |
JPH06312919A (ja) * | 1993-05-06 | 1994-11-08 | Kao Corp | 美白剤及びこれを含有する皮膚化粧料 |
JPH06321751A (ja) * | 1993-05-07 | 1994-11-22 | Kao Corp | 美白剤 |
JPH06321749A (ja) * | 1993-05-07 | 1994-11-22 | Kao Corp | 美白剤 |
JPH06321754A (ja) * | 1993-05-10 | 1994-11-22 | Kao Corp | 美白剤 |
JPH0761919A (ja) * | 1993-08-26 | 1995-03-07 | Kao Corp | 美白剤 |
JP2003500452A (ja) * | 1999-05-27 | 2003-01-07 | アーマディーロ・ファーマシューティカルス・インコーポレーテッド | 天然資源から抽出した生物活性物質の医薬製剤 |
JP2006522150A (ja) * | 2003-04-04 | 2006-09-28 | ユニゲン・ファーマシューティカルス・インコーポレーテッド | 哺乳動物の皮膚のケアのためのシクロオキシゲナーゼ(cox)およびリポキシゲナーゼ(lox)の二重の阻害薬の製剤 |
Non-Patent Citations (1)
Title |
---|
JPN6012064299; Kakeya, Hideaki et al: FEBS Letters Vol.320, No.2, 1993, p.169-172 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101114141B1 (ko) | 2009-08-31 | 2012-02-20 | (주)아모레퍼시픽 | 항산화용 화장료 조성물 |
US20110305779A1 (en) * | 2010-06-10 | 2011-12-15 | Cowan Fred M | Phytochemical combinations that regulate pathological immunity |
JP2012131748A (ja) * | 2010-12-22 | 2012-07-12 | Kao Corp | 抗酸化剤 |
CN105663595A (zh) * | 2016-02-29 | 2016-06-15 | 中国医学科学院药用植物研究所云南分所 | 一种黑色素抑制剂、护肤组合物及其应用 |
CN105663595B (zh) * | 2016-02-29 | 2019-09-06 | 中国医学科学院药用植物研究所云南分所 | 一种黑色素抑制剂、护肤组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
JP5220346B2 (ja) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5162174B2 (ja) | 育毛剤及び抗肥満剤 | |
JP2009046465A (ja) | 皮膚化粧料及び飲食品 | |
JP5512067B2 (ja) | 皮膚化粧料 | |
JP5220346B2 (ja) | 皮膚化粧料 | |
JP3933511B2 (ja) | 皮膚化粧料及び美容用飲食品 | |
JP5612267B2 (ja) | 皮膚化粧料 | |
JP6055667B2 (ja) | コラーゲン産生促進剤 | |
JP4672269B2 (ja) | 抗老化剤、血小板凝集抑制剤、抗酸化剤、抗アレルギー剤、皮膚化粧料及び飲食品 | |
JP5534654B2 (ja) | 抗炎症剤 | |
JP2012162487A (ja) | 美白剤、抗老化剤及び皮膚化粧料 | |
JP2006008571A (ja) | 保湿剤、抗酸化剤、抗老化剤、皮膚化粧料及び美容用飲食品 | |
JP5867981B2 (ja) | マトリックスメタロプロテアーゼ−1(mmp−1)活性阻害剤、エストロゲン様作用剤、i型コラーゲン産生促進剤、ヒアルロン酸産生促進剤、及びuv−bダメージからの回復剤 | |
JP5300233B2 (ja) | 皮膚化粧料 | |
JP5307366B2 (ja) | 育毛剤 | |
JP5085198B2 (ja) | 抗酸化剤 | |
JP5419258B2 (ja) | 化粧料 | |
JP7361412B2 (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP5419259B2 (ja) | 化粧料 | |
JP6993628B2 (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP6981685B2 (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP5361431B2 (ja) | 抗酸化剤 | |
JP4215252B2 (ja) | 抗酸化剤並びに皮膚化粧料及び美容用飲食品 | |
JP5719882B2 (ja) | サイクリックAMP−ホスホジエステラーゼ活性阻害剤、エラスターゼ活性阻害剤、マトリックスメタロプロテアーゼ−1(MMP−1)活性阻害剤、マトリックスメタロプロテアーゼ−14(MMP−14)活性阻害剤、表皮角化細胞増殖促進剤、エストロゲン様作用剤、エンドセリン−1mRNA発現上昇抑制剤及びSCFmRNA発現上昇抑制剤 | |
JP2016079155A (ja) | 皮膚化粧料、頭髪化粧料および飲食品 | |
JP2010184874A (ja) | 抗酸化剤、抗肥満剤、皮膚化粧料及び飲食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100525 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120912 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130212 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130227 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130306 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160315 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5220346 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |